| All Entries | New Antibodies | Research News | About antibodies-online.com |
Censoring of Autoreactive B Cell Development by the Pre-B Cell Receptor
The pre-B cell receptor appears to censor the development of certain autoantibody-secreting cells, as Rebecca A. Keenan and her team from The Babraham Institute in Cambridge, UK report. The pre-B cell receptor is composed of immunoglobulin (Ig) heavy and substitute light chains. It seems to be involved in the negative selection of cells expressing heavy chains bearing the potential to generate autoantibodies. It thus may be an important factor in multifactorial autoimmune diseases.
In this study, elevated levels of antinuclear antibodies were found in the serum of surrogate light-chain–deficient mice. There was also evidence of pre-B cells expressing prototypic autoantibody heavy chains. Those pre-B cells probably escaped negative selection and matured to autoantibody secreting CD21–CD23–B cells in the periphery.
Related antibodies on antibodies-online.com:
Pre-B-cells
Antibodies for the research area immunology: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

